Skip to Content

Rivastigmine 3M Health Care Ltd

Active Substance: rivastigmine
Common Name: rivastigmine
ATC Code: N06DA03
Marketing Authorisation Holder: 3M Health Care Limited
Active Substance: rivastigmine
Status: Withdrawn
Authorisation Date: 2014-04-03
Therapeutic Area: Alzheimer Disease
Pharmacotherapeutic Group: Transdermal patch

Therapeutic Indication

Symptomatic treatment of mild to moderately severe Alzheimer's dementia. 

The marketing authorisation for Rivastigmine 3M Health Care Ltd has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide